SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001140361-17-007375
Filing Date
2017-02-14
Accepted
2017-02-14 17:05:35
Documents
1

Document Format Files

Seq Description Document Type Size
1 PENTWATER CAPITAL MANAGEMENT LP SC 13GA NO 2 12-31-2016 (ESPERION THERAPEUTICS, formsc13ga.htm SC 13G/A 63242
  Complete submission text file 0001140361-17-007375.txt   64769
Mailing Address 614 DAVIS STREET EVANSTON IL 60201
Business Address 614 DAVIS STREET EVANSTON IL 60201 312-589-6400
Pentwater Capital Management LP (Filed by) CIK: 0001425851 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE
Type: SC 13G/A

Mailing Address 3891 RANCHERO DRIVE, SUITE 150 ANN ARBOR MI 48108
Business Address 3891 RANCHERO DRIVE, SUITE 150 ANN ARBOR MI 48108 734-887-3903
Esperion Therapeutics, Inc. (Subject) CIK: 0001434868 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-87536 | Film No.: 17610209
SIC: 2834 Pharmaceutical Preparations